Italia markets close in 5 hours 21 minutes

Agfa-Gevaert NV (0MFU.L)

LSE - LSE Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
3,55350,0000 (0,00%)
In data: 06:16PM BST. Mercato aperto.
Schermo intero
Chiusura precedente3,5535
Aperto3,5550
DenaroN/D x N/D
LetteraN/D x N/D
Min-Max giorno3,4850 - 3,5150
Intervallo di 52 settimane1,8540 - 3,5150
Volume1.359
Media Volume12.005
CapitalizzazioneN/D
Beta (5 anni mensile)0,63
Rapporto PE (ttm)N/D
EPS (ttm)N/D
Prossima data utiliN/D
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Publication of a transparency notification – Regulated information

    Publication of a transparency notification – Regulated information(Article 14 of the law of May 2, 2007 on the disclosure of significant shareholdings) Mortsel, Belgium – September 8, 2023 – 7.45 a.m. CET According to Agfa-Gevaert NV’s bylaws, the threshold as from which a shareholding needs to be disclosed, has been set at 3%, 5% and a multiple of 5%. In conformity with the Law of May 2, 2007 regarding the disclosure of significant shareholdings in listed companies, Agfa-Gevaert (Euronext: AGFB

  • GlobeNewswire

    The Agfa-Gevaert Group in Q2 2023: continued progress for the growth engines

    Regulated information – August 23, 2023 - 7:45 a.m. CET The Agfa-Gevaert Group in Q2 2023: continued progress for the growth engines HealthCare IT: Increase in order intake of 11%, revenue increase of 8%Quarter-on-quarter profitability improvement, but service margins under pressure due to cost inflation Digital Print & Chemicals: Good performance of the ZIRFON and Digital Print growth enginesProfitability improvements for ZIRFON and Digital Print offset by: weakness in the electronics industry,

  • GlobeNewswire

    The Agfa-Gevaert Group in Q1 2023 - regulated information

    Regulated information – May 9, 2023 - 7:45 a.m. CET The Agfa-Gevaert Group in Q1 2023: HealthCare IT: Increase in order intake of 25%, 4.8% revenue increaseProfitability impacted by cost inflation and unfavorable mix effects Digital Print & Chemicals: Growth driven by Digital Printing and Zirfon membranesSuccessful price increase actions and cost reductions allowed to restore profitability Radiology Solutions: Medical film: volume recovery in China but continuing margin pressure and geopolitical